Topical and Intradermal Efficacy of Photodynamic Therapy with Methylene Blue and Light-Emitting Diode in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis
Journal of Lasers in Medical Sciences,
Vol. 6 No. 3 (2015),
,
Page 106-111
Abstract
Introduction: The topical and intradermal photodynamic therapy (PDT) effect of methylene blue (MB) using light-emitting diode (LED) as light source (MB/LED-PDT) in the treatment of lesions of American cutaneous leishmaniasis (ACL) caused by Leishmania braziliensis in hamsters were investigated.
Methods: Hamsters were infected in the footpad with 4×107 promastigotes of L. braziliensis and divided in 4 groups: Control group was not treated, AmB group was treated with amphotericin B, MB-Id group received intradermal MB at the edge of the lesion and MB-Tp group received MB topic. After treatment with MB, the animals were illuminated using red LEDs at the 655 nm wavelength for 1 hour. The MB/LED-PDT was carried out three times a week for 12 weeks.
Results: Animals of MB-Tp group presented lesion healing with significant diminution in extent of the lesion, and reduced parasite burden compared to control group; however, no significant difference was seen compared to the AmB group. MB-Tp group also showed reconstitution of the epithelium, the formation of collagen fibers, organization in the epidermis, a little disorganization and inflammation in the dermis. MB-Id was ineffective in all parameters evaluated, and it was comparable to the control group results.
Conclusion: These data show that PDT with the use of MB-Tp and LED may be an alternative for the treatment of ACL. However, additional studies are being conducted to assess the potential of MB/LED-PDT, alone or in combination with conventional therapy, for the treatment of ACL.
- Photodynamic therapy
- Cutaneous leishmaniasis
- Leishmania braziliensis
- Treatment
How to Cite
References
Gontijo B, Carvalho MLR. Leishmaniose tegumentar Americana. Rev Soc Bras Med Trop. 2003;36:71-80. doi:10.1590/s0037-86822003000100011.
Reis AB, Gontijo CM. Leishmaniose Tegumentar Americana. In: Neves DP, ed. Parasitologia Humana. 12th ed. São Paulo, SP: Editora Ateneu; 2011:49-65.
World Health Organization. Leishmaniasis. http://www. who.int/topics/leishmaniasis/en/. Accessed Jul 17, 2014.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. 2013. Manual de Vigilância da Leishmaniose Tegumentar Americana, 2nd ed, Editora do Ministério da Saúde, Brasília, DF. http://portal.saude.gov.br/portal/ arquivos/pdf/manual2_lta_2ed.pdf
Gardlo K, Horska Z, Enk CD, et al. Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol. 2003;48:893-896. doi:10.1067/ mjd.2003.218.
Machado AE. Terapia Fotodinâmica: princípios, potencial de aplicação e perspectivas. Química Nova. 2000;23:237-243.
Enk C, Fritsch C, Jonas F, et al. Treatment of cutaneous leishmaniasis by photodynamic therapy. Arch Dermatol. 2003;139:432-434. doi:10.1001/archderm.139.4.432.
Akilov OE, Kosaka K, O’Riordan K, Hasan T. Parasiticidal effect of d-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells. Exp Dermatol. 2007;6:1067-1075. doi:10.1111/ j.1600-0625.2007.00578.x.
van der Snoek EM, Robinson DJ, van Hellemond JJ, Neumann HA. A review of photodynamic therapy in cutaneous leishmaniasis. J Eur Acad Dermatol Venereol. 2008;22:918-922. doi:10.1111/j.1468- 3083.2008.02805.x.
Wainwright M, Crossley K B. Methylene blue – a therapeutic dye for all seasons. J Chemother. 2002;14:431-443. doi:10.1179/joc.2002.14.5.431.
Calzavara-Pinton PG, Venturini M, Sala R. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B Biol. 2005;78:1-6. doi:10.1016/j. jphotobiol.2004.06.006.
Peloi LS, Biondo CE, Kimura E, et al. Photodynamic therapy for American Cutaneous Leishmaniasis: the efficacy of methylene blue in hamsters experimentally infected with Leishmania (Leishmania) amazonensis. Exp Parasitol. 2011;12:353-356.
Buffet PA, Sulahian A, Ganin YJF, Nassar N, Deuroin F. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother. 1995;39:2167- 2164. doi:10.1128/aac.39.9.2167
Akilov OE, Kosaka K, O’Riordan K, Hasan T. Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation. Photochem Photobiol Sci. 2007;6:1067- 1075. doi:10.1039/b703521g.
Shaha C. Apoptosis in Leishmania species & its relevance to disease pathogenesis. Indian J Med Res. 2006;123:233-244.
Akilov OE, Wu MX, et al. Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells. Photodermatol Photoimmunol Photomed. 2011;27:97-107.
Akilov OE, Kosaka K, O’Riordan K, et al. The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites. J Chem Biol. 2006;13:839-847.
Bristow CA, Hudson R, Paget TA, Boyle RW. Potential of cationic porphyrins for photodynamic treatment of cutaneous Leishmaniasis. Photodiagnosis Photodyn Ther. 2006;3:162-167.
Dutta S, Ray D, Kolli BK, Chang KP. Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitro. Antimicrob Agents Chemother. 2005;49:4474-4484. doi:10.1128/aac.49.11.4474-4484.2005
Sternberg ED, Dolphin D. Pyrrolic photosensitizers. Curr Med Chem. 1996;3:293-324.
Sternberg ED, Dolphin D, Bruckner C. Porphyrin-based photosensitizers for use in photodynamic therapy. Tetrahedron. 1998;54:4151-4202. doi:10.1016/S0040- 4020(98 )00015-5.
- Abstract Viewed: 849 times
- PDF Downloaded: 326 times
